Takeda Pharmaceutical Co Stock Performance
| TKPHF Stock | USD 25.12 0.67 2.74% |
The entity has a beta of -0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Takeda Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Takeda Pharmaceutical is likely to outperform the market. At this point, Takeda Pharmaceutical has a negative expected return of -0.16%. Please make sure to validate Takeda Pharmaceutical's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Takeda Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 966.2 B | |
| Total Cashflows From Investing Activities | -198.1 B |
Takeda |
Takeda Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,858 in Takeda Pharmaceutical Co on September 29, 2024 and sell it today you would lose (346.00) from holding Takeda Pharmaceutical Co or give up 12.11% of portfolio value over 90 days. Takeda Pharmaceutical Co is currently producing negative expected returns and takes up 2.9068% volatility of returns over 90 trading days. Put another way, 25% of traded pink sheets are less volatile than Takeda, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Takeda Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Takeda Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Takeda Pharmaceutical Co, and traders can use it to determine the average amount a Takeda Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.056
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TKPHF |
Estimated Market Risk
| 2.91 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Takeda Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Takeda Pharmaceutical by adding Takeda Pharmaceutical to a well-diversified portfolio.
Takeda Pharmaceutical Fundamentals Growth
Takeda Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Takeda Pharmaceutical, and Takeda Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Takeda Pink Sheet performance.
| Return On Equity | 0.0477 | |||
| Return On Asset | 0.0247 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 75.53 B | |||
| Shares Outstanding | 1.56 B | |||
| Price To Earning | 27.54 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 3.57 T | |||
| EBITDA | 1.05 T | |||
| Cash And Equivalents | 645.99 B | |||
| Cash Per Share | 417.82 X | |||
| Total Debt | 4.14 T | |||
| Debt To Equity | 0.81 % | |||
| Book Value Per Share | 3,973 X | |||
| Cash Flow From Operations | 1.12 T | |||
| Earnings Per Share | 1.33 X | |||
| Total Asset | 13.18 T | |||
| Retained Earnings | 1.57 T | |||
| Current Asset | 1.48 T | |||
| Current Liabilities | 808.72 B | |||
About Takeda Pharmaceutical Performance
By analyzing Takeda Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Takeda Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Takeda Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Takeda Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47347 people.Things to note about Takeda Pharmaceutical performance evaluation
Checking the ongoing alerts about Takeda Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Takeda Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Takeda Pharmaceutical generated a negative expected return over the last 90 days |
- Analyzing Takeda Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Takeda Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Takeda Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Takeda Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Takeda Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Takeda Pharmaceutical's pink sheet. These opinions can provide insight into Takeda Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets |